Directed differentiation of human pluripotent stem cells into epidermal stem and progenitor cells.
Directed differentiation of human pluripotent stem cells into epidermal stem and progenitor cells.
复制标题
DOI:
10.1007/s11033-021-06588-3
复制
发表时间:
2021-08
影响因子:
2.8
通讯作者:
Wells SI
中科院分区:
文献类型:
--
作者:
Ruiz-Torres S;Lambert PF;Wikenheiser-Brokamp KA;Wells SI
Induced pluripotent stem cells (PSCs) produced by somatic cell reprogramming self-renew in culture and can, in principle, differentiate into any cell type. These cells represent a powerful tool for disease modeling, drug screening, regenerative medicine, and the discovery of personalized therapies to treat tissue-specific pathologies. We have previously reported the directed differentiation of human PSCs into epidermal stem and progenitor cells (ESPCs) and 3D stratified epidermis to model the inherited syndrome Fanconi anemia (FA). Epidermal cell junctional defects discovered in this published system were validated in FA patient populations. Herein, we describe in detail the corresponding 20-day protocol for generating a renewable source of PSC-derived keratinocytes using a distinct PSC line (209.2 PSC). This approach modifies previous protocols to minimize spontaneous cell death and terminal differentiation, eliminate cell stress-inducing keratinocyte selection steps, and reduce total protocol duration and cost. Independent donor-derived PSC lines were converted into ESPCs through the addition of relevant morphogens and a Rho-associated protein kinase (ROCK) inhibitor. Results for the normal 209.2 PSC line highlight consistencies in 2D and also variable features in the resulting 3D epidermis compared to the previously published FA PSC lines. 209.2 PSC-derived ESPCs exhibited a basal cell phenotype based on marker analysis, while maintaining the capacity to be engineered into PSC-derived epidermal organotypic rafts with morphology consistent with fetal epidermis. Furthermore, transcriptional analyses to determine keratinocyte identity demonstrated 209.2 PSC-derived ESPCs express epidermis-selective markers and not early endoderm markers, thus supporting an immature stage of p63+ epidermal development. This protocol provides an accelerated path for the generation of human ESPCs and derivative 3D epidermal models to study normal epidermal development and homeostasis, elucidate mechanisms of epidermal disease pathogenesis, and provides a platform for developing personalized therapies.
登录
查看更多内容
影响因子:
5.2
作者:
Dabelsteen, Sally;Hercule, Paula;Barron, Patricia;Rice, Meghan;Dorsainville, Gregory;Rheinwald, James G.
通讯作者:
Rheinwald, James G.
影响因子:
2.4
作者:
Fisher JB;Pulakanti K;Rao S;Duncan SA
通讯作者:
Duncan SA
影响因子:
5.8
作者:
Schmook, FP;Meingassner, JG;Billich, A
通讯作者:
Billich, A
影响因子:
9.2
作者:
McMullan, R;Lax, S;Hotchin, NA
通讯作者:
Hotchin, NA
DOI:
10.1387/ijdb.170341fw
发表时间:
2018
期刊:
The International journal of developmental biology
影响因子:
--
作者:
Belokhvostova D;Berzanskyte I;Cujba AM;Jowett G;Marshall L;Prueller J;Watt FM
通讯作者:
Watt FM